Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Randomized phase III trial to compare the effectiveness of irinotecan with that of
combination chemotherapy in treating patients who have advanced colorectal cancer that has
not responded to previous treatment. Drugs used in chemotherapy use different ways to stop
tumor cells from dividing so they stop growing or die. Combining more than one drug may kill
more tumor cells. It is not yet known which chemotherapy regimen is more effective for
colorectal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
National Cancer Institute (NCI)
Collaborators:
Eastern Cooperative Oncology Group Southwest Oncology Group